PHENSERINE, (+)- Drug Record

  • PHENSERINE, (+)- chembl:CHEMBL4297417

    Alternate Names:

    POSIPHEN
    PHENSERINE, (+)-

    Drug Info:

    FDA Approval not approved
    Drug Class small molecule
    Drug Indications for treatment of Alzheimer's disease
    (0 More Sources)

    Publications:

  • PHENSERINE, (+)-   BACE2

    Interaction Score: 20.61

    Interaction Types & Directionality:
    n/a

    Interaction Info:
    Trial Name Posiphen
    Novel drug target Novel Target

    PMIDs:
    None found


    Sources:
    TdgClinicalTrial

  • PHENSERINE, (+)-   BACE1

    Interaction Score: 1.21

    Interaction Types & Directionality:
    n/a

    Interaction Info:
    Trial Name [(+)-phenserine tartrate,Posiphen
    Novel drug target Novel Target
    Trial Name Posiphen

    PMIDs:
    None found


    Sources:
    TdgClinicalTrial

  • PHENSERINE, (+)-   APP

    Interaction Score: 0.66

    Interaction Types & Directionality:
    n/a

    Interaction Info:
    Trial Name Posiphen
    Novel drug target Novel Target
    Trial Name [(+)-phenserine tartrate,Posiphen

    PMIDs:
    None found


    Sources:
    TdgClinicalTrial

  • TdgClinicalTrial: POSIPHEN

    • Version: January-2014

    Alternate Names:

    Drug Info:
    Drug Indications for treatment of Alzheimer's disease
    Drug Class small molecule
    FDA Approval not approved

    Publications:

  • ChemblDrugs: chembl:CHEMBL4297417

    • Version: ChEMBL_27

    Alternate Names:

    Drug Info:

    Publications: